Status:
TERMINATED
Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery
Lead Sponsor:
Catharina Ziekenhuis Eindhoven
Conditions:
Heart; Dysfunction Postoperative, Cardiac Surgery
Anemia, Iron-Deficiency
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Pre-treatment of patients with erythropoietin subcutaneously and iron supplement intravenously, in order to create a clinical pathway to minimize transfusion of red blood cells in a selected group of ...
Detailed Description
Blood transfusion is identified as an independent predictor of early mortality after Coronary artery bypass grafting operations In addition, female gender, lower body surface area (BSA), low preoperat...
Eligibility Criteria
Inclusion
- Undergoing isolated Coronary Artery Bypass Grafting operation or Aortic Valve Repair (AVR).
- Preoperative Hb \< 7 mmol/l.
Exclusion
- Off pump surgery.
- Combination surgery.
- Re-operation.
- Emergency operation.
- Patients with bleeding disturbances; e.g, hemophilia and patients with chronic liver disease.
- Concomitant use of cyclosporine prior to, during or following surgery.
- Female patients who are pregnant or planning to become pregnant.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT02210949
Start Date
August 1 2014
End Date
April 1 2017
Last Update
April 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catharina Hospital
Eindhoven, North Brabant, Netherlands, 5602 ZA